Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,951 | -4,861 | -18,972 | -16,005 | -12,770 |
| Depreciation Amortization | -7 | 1 | 256 | 234 | 182 |
| Accounts payable and accrued liabilities | 868 | 608 | -261 | 358 | 482 |
| Other Working Capital | 1,840 | 1,089 | -1,940 | -1,898 | -572 |
| Other Operating Activity | 411 | 25 | 2,634 | 1,576 | 992 |
| Operating Cash Flow | $-7,839 | $-3,139 | $-18,282 | $-15,735 | $-11,685 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -60 | -60 | -60 |
| Purchase Of Investment | -11,151 | -6,972 | -25,272 | -19,214 | -3,977 |
| Sale Of Investment | 21,265 | 8,400 | 28,568 | 19,680 | 8,060 |
| Other Investing Activity | 0 | 0 | -7 | -7 | -7 |
| Investing Cash Flow | $10,114 | $1,428 | $3,229 | $400 | $4,017 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,796 | 3,087 | 606 | 34 | 34 |
| Financing Cash Flow | $8,796 | $3,087 | $606 | $34 | $34 |
| Beginning Cash Position | 5,561 | 5,561 | 20,008 | 20,008 | 20,008 |
| End Cash Position | 16,631 | 6,937 | 5,561 | 4,707 | 12,373 |
| Net Cash Flow | $11,071 | $1,376 | $-14,447 | $-15,301 | $-7,635 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,839 | -3,139 | -18,282 | -15,735 | -11,685 |
| Capital Expenditure | N/A | N/A | -60 | -60 | -60 |
| Free Cash Flow | -7,839 | -3,139 | -18,342 | -15,795 | -11,745 |